At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 17, 2026 at 20:47 ET
Two directors at Arcutis Biotherapeutics sold a combined $221K in open-market transactions over a 7-day window. The total value represents approximately 0.007% of the company's $3.2B market cap, making this a trivial cluster with no material signal for traders.
- Two directors (Welgus Howard G. and LIN SUE-JEAN) sold shares totaling $221K
- Total sales represent ~0.007% of ARQT's $3.2B market cap
- Welgus also exercised non-cash derivative transactions (822 shares at $0 and 822 shares at $6.52) alongside the sales
- No C-suite executives participated in the cluster
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access